News

TipRanks on MSN4d

AbbVie’s Phase 3 Study on Upadacitinib for Hidradenitis Suppurativa: A Potential Game Changer

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...
TipRanks on MSN5d

AbbVie’s Promising Phase 3 Study on Upadacitinib for Takayasu Arteritis

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 study, officially ...
PMLive6d

AbbVie shares promising phase 3 results for Rinvoq in severe alopecia areata

AbbVie has shared promising top-line results from a late-stage study of its JAK inhibitor Rinvoq (upadacitinib) in severe ...